logo
Why Tesla Stock Is Soaring Today Even as Tariff Trouble Mounts

Why Tesla Stock Is Soaring Today Even as Tariff Trouble Mounts

Yahoo09-04-2025

Shares of Tesla (NASDAQ: TSLA) are rebounding on Wednesday. The electric vehicle (EV) stock gained 5.2% as of 1:05 p.m. ET after gaining 6.4% earlier in the day. The bounce comes as the S&P 500 and Nasdaq Composite were green even as more retaliatory tariffs on the U.S. were announced.
A Wall Street firm added Tesla to its "best ideas" list despite recent troubles, claiming the stock sell-off is overdone.
Benchmark analyst Mickey Legg released a bullish research note on Wednesday, adding Tesla to the firm's "best ideas" list. The analyst acknowledged the stock's recent struggles amid declining sales but said he believes concerns "are overblown considering the near-term issues impacting the company and the scope of opportunities around the corner."
Legg did lower his price target to $350 from $475, but that still represents a large upside from the stock's current price around $230. Benchmark maintained a buy rating on the stock.
The analyst's optimism centers on Tesla's anticipated product launches that could reverse the company's recent sales decline. "Our focus is on the release of a new TSLA model in [the 2025 second quarter], which in our view could turn around the recent decline in vehicle sales," Legg wrote. He also thinks that Tesla's robotaxi service, scheduled to launch this summer in Austin, Texas, could be a significant catalyst.
The company is promising the release of a personal robot named Optimus. Legg describes it as a possible game changer that transforms the company from a vehicle manufacturer into a broad automation provider. This aligns with CEO Elon Musk's recent statement that Tesla plans to build 5,000 Optimus robots this year.
While these plans could indeed be a game changer, their success is far from guaranteed. Neither is the timeline of their release. Musk has a history of big promises that fail to materialize. It's been nearly a decade since the enigmatic CEO chief said that his cars would soon be fully autonomous, but he still has yet to deliver on that core promise. I would avoid Tesla stock for the time being.
Ever feel like you missed the boat in buying the most successful stocks? Then you'll want to hear this.
On rare occasions, our expert team of analysts issues a 'Double Down' stock recommendation for companies that they think are about to pop. If you're worried you've already missed your chance to invest, now is the best time to buy before it's too late. And the numbers speak for themselves:
Nvidia: if you invested $1,000 when we doubled down in 2009, you'd have $249,730!*
Apple: if you invested $1,000 when we doubled down in 2008, you'd have $32,689!*
Netflix: if you invested $1,000 when we doubled down in 2004, you'd have $469,399!*
Right now, we're issuing 'Double Down' alerts for three incredible companies, available when you join , and there may not be another chance like this anytime soon.*Stock Advisor returns as of April 5, 2025
Johnny Rice has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Tesla. The Motley Fool has a disclosure policy.
Why Tesla Stock Is Soaring Today Even as Tariff Trouble Mounts was originally published by The Motley Fool

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Drug maker Indivior to abandon London stock market for the US
Drug maker Indivior to abandon London stock market for the US

Yahoo

time13 minutes ago

  • Yahoo

Drug maker Indivior to abandon London stock market for the US

Drug maker Indivior has announced plans to delist its shares from the London Stock Exchange (LSE), marking the latest company to abandon the UK market for the US. However, the LSE welcomes Anglo-American's platinum spin-off Valterra after becoming independent from the mining giant. Indivior's exit comes after the company moved its primary listing to the US's Nasdaq index last year. It said cancelling the secondary listing in London eliminates 'cost and complexity' and better reflects the business – with more than 80% of its revenues generated in the US. It also said liquidity on the Nasdaq now 'far outweighs' that of the LSE with a greater level of trading. The US-based pharmaceutical firm makes prescription medicines to treat opioid addiction, and has a market capitalisation of £1.2 billion. 'A single primary listing on Nasdaq best reflects the profile of Indivior's business,' chairman David Wheadon said. 'We appreciate the support received from shareholders for this initiative and look forward to capitalising on the expected benefits of this move, including reductions in cost and complexity.' The LSE faced the largest exodus of companies since the global financial crisis in 2024, according to EY analysis. There were 88 companies to delist or transfer their primary listing from the main market – the most since 2009. At the same time, the LSE struggled to attract as many new companies to fill the gaps – with 18 new listings in total last year. Nevertheless, Indivior's exit, which will take effect from July 25, comes as Valterra Platinum makes its debut on the London market. Anglo American spun off its platinum business into the new entity, which has become the world's most valuable producer of the metal. Valterra will have its secondary listing on the LSE, with its primary on the Johannesburg Stock Exchange. Duncan Wanblad, Anglo American's chief executive, said: 'Valterra Platinum has been a major part of the company for many years but now is the right time for it to optimise its value creation prospects on an independent path – it's an outstanding business and team and I have every confidence that Valterra Platinum will thrive as a leader in the global platinum group metals industry.' Sign in to access your portfolio

Ollie's (OLLI) Reports Q1: Everything You Need To Know Ahead Of Earnings
Ollie's (OLLI) Reports Q1: Everything You Need To Know Ahead Of Earnings

Yahoo

time29 minutes ago

  • Yahoo

Ollie's (OLLI) Reports Q1: Everything You Need To Know Ahead Of Earnings

Discount retail company Ollie's Bargain Outlet (NASDAQ:OLLI) will be announcing earnings results tomorrow before the bell. Here's what you need to know. Ollie's missed analysts' revenue expectations by 1.2% last quarter, reporting revenues of $667.1 million, up 2.8% year on year. It was a mixed quarter for the company, with an impressive beat of analysts' gross margin estimates but full-year EPS guidance missing analysts' expectations. Is Ollie's a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Ollie's revenue to grow 11.3% year on year to $566.2 million, in line with the 10.8% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.71 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Ollie's has missed Wall Street's revenue estimates four times over the last two years. Looking at Ollie's peers in the discount retailer segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Ross Stores delivered year-on-year revenue growth of 2.6%, beating analysts' expectations by 0.5%, and TJX reported revenues up 5.1%, topping estimates by 0.7%. Ross Stores traded down 9.8% following the results while TJX was also down 4%. Read our full analysis of Ross Stores's results here and TJX's results here. There has been positive sentiment among investors in the discount retailer segment, with share prices up 9.8% on average over the last month. Ollie's stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $125.88 (compared to the current share price of $110). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store